Basics Glaukos Corporation Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. IPO Date: June 25, 2015 Sector: Healthcare Industry: Medical Instruments and Equipment Market Cap: $5.39B Activated in VL: True Average Daily Range Avg Daily Range: $1.14 | 2.02% Avg Daily Range (30 D): $1.56 | 1.71% Avg Daily Range (90 D): $1.53 | 1.62% Institutional Daily Volume Avg Daily Volume: .47M Avg Daily Volume (30 D): .88M Avg Daily Volume (90 D): .82M Trade Size Avg Trade Size (Sh.): 70 Avg Trade Size (Sh.) (30 D): 48 Avg Trade Size (Sh.) (90 D): 45 Institutional Trades Total Inst.Trades: 5,660 Avg Inst. Trade: $2.93M Avg Inst. Trade (30 D): $4.75M Avg Inst. Trade (90 D): $5.55M Avg Inst. Trade Volume: .04M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $4.11M Avg Closing Trade (30 D): $9.73M Avg Closing Trade (90 D): $11.57M Avg Closing Volume: 58.45K     News Sep 4, 2025 @ 5:30 AM Nicox prévoit de rembourser intégralement se... Source: Nicox Sa Sep 4, 2025 @ 5:30 AM Nicox Expects to Fully Repay Financial Debts with ... Source: Gavin Spencer Sep 11, 2024 @ 6:20 PM Glaukos Stocks Rides on Strong Product Demand Amid... Source: Zacks Jul 16, 2024 @ 2:30 PM Will WATCHMAN Sales Aid Boston Scientific's (BSX) ... Source: N/A Jul 16, 2024 @ 2:06 PM Truist lifts Glaukos shares target, highlights str... Source: Emilio Ghigini Financials   TTM Q2 2025 Q1 2025 Basic EPS $-1.64 $-.34 $-.32 Diluted EPS $-1.64 $-.34 $-.32 Revenue $ 432.95M $ 124.12M $ 106.66M Gross Profit $ 330.52M $ 97.22M $ 82.35M Net Income / Loss $ -92.79M $ -19.66M $ -18.15M Operating Income / Loss $ -96.69M $ -22.69M $ -20.68M Cost of Revenue $ 102.43M $ 26.9M $ 24.32M Net Cash Flow $ 37.98M $ -11.56M $ -53.52M PE Ratio